Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Industry experts react to DTC advertising study findings
Industry experts agree that a recent study published in Cancer -- regarding the impact of direct-to-consumer advertising on prescribing for aromatase inhibitors -- shows the benefits of DTCA to patients. John Kamp, Executive Director for the Coalition for Healthcare Communication, said the study "is strong evidence supporting the value of marketing in the delivery of appropriate care, blowing away much of the unsupported criticism that marketing leads to inappropriate prescribing." Matt Giegerich, Ogilvy CommonHealth Worldwide Chairman & CEO, and Jim Davidson, Executive Director, The Advertising Coalition, also comment in this story posted on the Coalition's Website. Read more.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .